Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2008 1
2010 3
2012 3
2014 4
2015 4
2016 2
2017 3
2018 3
2019 2
2020 4
2021 2
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Harnessing innate immunity in cancer therapy.
Demaria O, Cornen S, Daëron M, Morel Y, Medzhitov R, Vivier E. Demaria O, et al. Nature. 2019 Oct;574(7776):45-56. doi: 10.1038/s41586-019-1593-5. Epub 2019 Oct 2. Nature. 2019. PMID: 31578484 Review.
New immune cell engagers for cancer immunotherapy.
Fenis A, Demaria O, Gauthier L, Vivier E, Narni-Mancinelli E. Fenis A, et al. Among authors: demaria o. Nat Rev Immunol. 2024 Jan 25. doi: 10.1038/s41577-023-00982-7. Online ahead of print. Nat Rev Immunol. 2024. PMID: 38273127 Review.
Antitumor immunity induced by antibody-based natural killer cell engager therapeutics armed with not-alpha IL-2 variant.
Demaria O, Gauthier L, Vetizou M, Blanchard Alvarez A, Vagne C, Habif G, Batista L, Baron W, Belaïd N, Girard-Madoux M, Cesari C, Caratini M, Bosco F, Benac O, Lopez J, Fenis A, Galluso J, Trichard S, Carrette B, Carrette F, Maguer A, Jaubert S, Sansaloni A, Letay-Drouet R, Kosthowa C, Lovera N, Dujardin A, Chanuc F, Le Van M, Bokobza S, Jarmuzynski N, Fos C, Gourdin N, Remark R, Lechevallier E, Fakhry N, Salas S, Deville JL, Le Grand R, Bonnafous C, Vollmy L, Represa A, Carpentier S, Rossi B, Morel A, Cornen S, Perrot I, Morel Y, Vivier E. Demaria O, et al. Cell Rep Med. 2022 Oct 18;3(10):100783. doi: 10.1016/j.xcrm.2022.100783. Cell Rep Med. 2022. PMID: 36260981 Free PMC article.
ISACs take a Toll on tumors.
Demaria O, Vivier E. Demaria O, et al. Nat Cancer. 2021 Jan;2(1):12-13. doi: 10.1038/s43018-020-00152-x. Nat Cancer. 2021. PMID: 35121891 No abstract available.
Immuno-Oncology beyond TILs: Unleashing TILCs.
Demaria O, Vivier E. Demaria O, et al. Cancer Cell. 2020 Apr 13;37(4):428-430. doi: 10.1016/j.ccell.2020.03.021. Cancer Cell. 2020. PMID: 32289267 Free article.
Avdoralimab (Anti-C5aR1 mAb) Versus Placebo in Patients With Severe COVID-19: Results From a Randomized Controlled Trial (FOR COVID Elimination [FORCE]).
Carvelli J, Meziani F, Dellamonica J, Cordier PY, Allardet-Servent J, Fraisse M, Velly L, Barbar SD, Lehingue S, Guervilly C, Desgrouas M, Camou F, Piperoglou C, Vely F, Demaria O, Karakunnel J, Fares J, Batista L, Rotolo F, Viotti J, Boyer-Chammard A, Lacombe K, Le Dault E, Carles M, Schleinitz N, Vivier E; FOR COVID Elimination (FORCE) Study Group. Carvelli J, et al. Among authors: demaria o. Crit Care Med. 2022 Dec 1;50(12):1788-1798. doi: 10.1097/CCM.0000000000005683. Epub 2022 Oct 10. Crit Care Med. 2022. PMID: 36218354 Free PMC article. Clinical Trial.
Netting Neutrophils Activate Autoreactive B Cells in Lupus.
Gestermann N, Di Domizio J, Lande R, Demaria O, Frasca L, Feldmeyer L, Di Lucca J, Gilliet M. Gestermann N, et al. Among authors: demaria o. J Immunol. 2018 May 15;200(10):3364-3371. doi: 10.4049/jimmunol.1700778. Epub 2018 Apr 9. J Immunol. 2018. PMID: 29632142
33 results